David Weinshenker

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice

Daniel F. Manvich, Kevin A. Webster, Stephanie L. Foster et al. · Scientific Reports · 2018 · 385 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

Dopamine supersensitivity correlates with D2 ^High states, implying many paths to psychosis

Philip Seeman, David Weinshenker, Rémi Quirion et al. · Proceedings of the National Academy of Sciences · 2005 · 351 citations

Medicine, Neuroscience, Pharmacology +16

Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity

T. Taylor, W. Michael Caudle, K. R. Shepherd et al. · Journal of Neuroscience · 2009 · 283 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer’s disease

Jacki M. Rorabaugh, Termpanit Chalermpalanupap, Christian Botz-Zapp et al. · Brain · 2017 · 251 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer’s Disease

Zhentao Zhang, Xia Liu, Jason P. Schroeder et al. · Neuropsychopharmacology · 2013 · 240 citations

Life Sciences, Neuroscience, Pharmacology +16